Beconase Hayfever Nasal Spray
Beconase Hayfever prevents and relieves nasal congestion, sneezing and a runny, itchy nose due to hayfever and other seasonal allergic conditions. Once nasal congestion is cleared the pressure and pain around the eyes is also reduced.
Regular usage is essential for full therapeutic benefit. Beconase Hayfever quickly starts to bring relief and reduce swelling in the nose although it may take a few days to build up to its maximum effect.
Adults 18 years of age and over:
The recommended dose is two applications into each nostril twice daily.
Total daily administration should not exceed 8 applications (400 mcg).
If there is no response after 14 days of treatment, medical advice should be sought.
Beconase Hayfever is for nasal use only.
Do not use continuously for longer than 3 months without consulting your doctor.
Infections of the nasal passages and paranasal sinuses should be appropriately treated but Beconase Hayfever therapy need not be stopped.
Care must be taken while transferring patients from systemic steroid treatment to Beconase Hayfever if there is any reason to suppose that their adrenal function is impaired.
Systemic effects including reduction in growth velocity may rarely occur with excessive use of the product.
Although Beconase Hayfever will control seasonal allergic rhinitis in most cases, additional therapy may be needed to control eye symptoms in the presence of abnormally heavy allergen challenges.
Medical advice should be sought before using Beconase Hayfever in the case of recent injury or surgery to the nose, or problems with ulceration in the nose.
Beconase Hayfever nasal spray contains benzalkonium chloride which may cause bronchospasm.
Each 100 mg spray contains beclometasone dipropionate monohydrate equivalent to 50 micrograms Beclometasone Dipropionate Ph.Eur.
Excipients: Each 100 mg spray contains benzalkonium chloride solution equivalent to benzalkonium chloride 20 micrograms.